Form 4: UTMD Director Gifts Shares

Sentiment:

Insider Transaction Report


Utah Medical Products Director Paul O. Richins reported gifting 100 shares of common stock on August 25, 2025.

Summary

  • Paul O. Richins, a Director of Utah Medical Products Inc. (UTMD), reported a gift of 100 shares of common stock.
  • The transaction occurred on August 25, 2025.
  • The shares were valued at $60.34 per share for the purpose of the gift.
  • Following this transaction, Mr. Richins beneficially owns 21,136 shares, including shares held indirectly through a spouse's IRA, sons, his own IRA, and the Richins Family Trust.

Sentiment

Score: 5

Explanation: A neutral event. A director gifted a small number of shares, which is a disposition but not a sale for cash, and does not significantly alter the overall insider ownership picture or company fundamentals.

Negatives

  • A director disposed of 100 shares of common stock, reducing their direct beneficial ownership.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

  • Shareholders: Minimal impact due to the small number of shares involved in the gift.

Key Dates

DateDescription
08/25/2025Date of gift transaction by Director Paul O. Richins.

Recommendation

hold

This Form 4 filing reports a routine, small-scale gift of shares by a director. It does not provide any new information regarding the company's operational performance, financial health, or strategic direction that would warrant a change in investment recommendation. The transaction itself is not significant enough to impact the stock's valuation or outlook.

Keywords

Utah Medical Products, UTMD, Paul O. Richins, Insider Transaction, Form 4, Director, Stock Gift, Common Stock

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.